Our findings, according to previous retrospective analyses and metanalyses (28, 33, 39, 40, 41), suggest a prognostic role for PR expression levels in luminal-like HER2 negative BC that should be confirmed prospectively. The gene discussed is ERBB2; the disease is breast cancer.